[The angina pectoris syndrome. II. Therapeutic principles].
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000787:Angina Pectoris / Q000188:drug therapy* / Q000517:prevention & control / Q000601:surgery; D002118:Calcium / Q000037:antagonists & inhibitors; D002301:Cardiac Glycosides / Q000627:therapeutic use; D006801:Humans; D005996:Nitroglycerin / Q000627:therapeutic use; D009599:Nitroprusside / Q000627:therapeutic use; D011619:Psychotropic Drugs / Q000627:therapeutic use; D013577:Syndrome; D014665:Vasodilator Agents / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D002301:Cardiac Glycosides; D011619:Psychotropic Drugs; D014665:Vasodilator Agents; D009599:Nitroprusside; D005996:Nitroglycerin; D002118:Calcium
Das Angina-pectoris-Syndrom. Teil II. Therapeutische Grundsätze.